Phase III INVIGORATE trial of reproxalap in allergic conjunctivitis meets endpoints April 28, 2021 No Comments
Apellis reports 24-month data from phase Ib study of pegcetacoplan in geographic atrophy April 14, 2021 No Comments
Phase III GOBI study of NOV-03 meets statistical significance on coprimary and secondary endpoints April 14, 2021 No Comments
Bayer initiates phase II study of runcaciguat in nonproliferative diabetic retinopathy April 8, 2021 No Comments
RSS